Matches in DBpedia 2016-04 for { ?s ?p "Professor Gordon McVie (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan.He has written over 300 peer-reviewed papers and editorials as well as contributing to numerous books. He currently serves on several committees including the American Association for Cancer Research and the American Society of Clinical Oncology. He also serves on the boards of the National Cancer Institutes of France, Italy and the Netherlands. In the UK, he has been on the boards of cancer institutes in Glasgow, Manchester and London.He is currently Director of Cancer Intelligence, providing advisory services to the media, patients, pharmaceutical and biotechnology companies as well as publishing ecancermedicalscience. McVie is a Senior Consultant at the European Institute of Oncology, Visiting Professor at Glasgow University, in Scotland, and Honorary Consultant in Medical Oncology at the Welsh Cancer Institute, Cardiff, Wales.He has formulated several substantial additions to the field of cancer care including establishing localised, more pin-point, administration of chemotherapy, and encouraging the use of chemotherapy for the treatment of lung cancer throughout the EU. He has also emphasised the importance of adjusting a patient’s management according to their ethnicity."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Gordon_McVie abstract "Professor Gordon McVie (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan.He has written over 300 peer-reviewed papers and editorials as well as contributing to numerous books. He currently serves on several committees including the American Association for Cancer Research and the American Society of Clinical Oncology. He also serves on the boards of the National Cancer Institutes of France, Italy and the Netherlands. In the UK, he has been on the boards of cancer institutes in Glasgow, Manchester and London.He is currently Director of Cancer Intelligence, providing advisory services to the media, patients, pharmaceutical and biotechnology companies as well as publishing ecancermedicalscience. McVie is a Senior Consultant at the European Institute of Oncology, Visiting Professor at Glasgow University, in Scotland, and Honorary Consultant in Medical Oncology at the Welsh Cancer Institute, Cardiff, Wales.He has formulated several substantial additions to the field of cancer care including establishing localised, more pin-point, administration of chemotherapy, and encouraging the use of chemotherapy for the treatment of lung cancer throughout the EU. He has also emphasised the importance of adjusting a patient’s management according to their ethnicity.".
- Q5585563 abstract "Professor Gordon McVie (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan.He has written over 300 peer-reviewed papers and editorials as well as contributing to numerous books. He currently serves on several committees including the American Association for Cancer Research and the American Society of Clinical Oncology. He also serves on the boards of the National Cancer Institutes of France, Italy and the Netherlands. In the UK, he has been on the boards of cancer institutes in Glasgow, Manchester and London.He is currently Director of Cancer Intelligence, providing advisory services to the media, patients, pharmaceutical and biotechnology companies as well as publishing ecancermedicalscience. McVie is a Senior Consultant at the European Institute of Oncology, Visiting Professor at Glasgow University, in Scotland, and Honorary Consultant in Medical Oncology at the Welsh Cancer Institute, Cardiff, Wales.He has formulated several substantial additions to the field of cancer care including establishing localised, more pin-point, administration of chemotherapy, and encouraging the use of chemotherapy for the treatment of lung cancer throughout the EU. He has also emphasised the importance of adjusting a patient’s management according to their ethnicity.".